Serological immune biomarker for disease severity in dengue‐infected pediatric hospitalized patients
Journal of Medical Virology · 2024
DOI: 10.1002/jmv.29779 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Virology, 2024. Verfasst von Bharti Pathak und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Medicine, Jamia Hamdard, Hamdard Nagar, New Delhi, India. Hauptthemen laut MEDLINE: Antibodies, Viral, Dengue, Dengue Virus, Severity of Illness Index. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 34 Literaturangaben.
Abstract (Originalsprache)
Clinical manifestation of dengue disease ranges from asymptomatic, febrile fever without warning sign (DOS) to serious outcome dengue with warning sign (DWS) and severe disease (SD) leading to shock syndrome and death. The role of antibody response in natural dengue infection is complex and not completely understood. Here, we aimed to assess serological marker for disease severity. Antibody response of dengue‐confirmed pediatric patients with acute secondary infection were evaluated against infecting virus, immature virus, and recombinant envelop protein. Immature virus antibody titers were significantly higher in DWS as compared to DOS ( p = 0.0006). However, antibody titers against recombinant envelop protein were higher in DOS as compared to DWS, and antibody avidity was significantly higher against infecting virus in DOS. Serum samples of DOS patients displayed higher in vitro neutralization potential in plaque assay as compared to DWS, whereas DWS serum samples showed higher antibody‐dependent enhancement in the in vitro enhancement assays. Thus, antibodies targeting immature virus can predict disease severity and could be used in early forecast of disease outcome using an enzyme‐linked immunoassay assay system which is less laborious and cheaper than plaque assay system for correlates of protection and could help optimize medical care and resources.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Medicine, Jamia Hamdard, Hamdard Nagar, New Delhi, India.
- Department of Paediatrics, Hamdard Institute of Medical Sciences and Research, Jamia Hamdard, New Delhi, India.
- Department of Paediatrics, Amrita Institute of Medical Sciences, Faridabad, Haryana, India.
- School of Sciences, IGNOU, New Delhi, India.
ORCID-Profile: Anuja Krishnan
Zitieren
APA
Pathak, B., Chakarvarty, A., Rani, N. V., & Krishnan, A. (2024). Serological immune biomarker for disease severity in dengue‐infected pediatric hospitalized patients. Journal of Medical Virology. https://doi.org/10.1002/jmv.29779
Vancouver
Pathak B, Chakarvarty A, Rani NV, Krishnan A. Serological immune biomarker for disease severity in dengue‐infected pediatric hospitalized patients. Journal of Medical Virology. 2024. doi:10.1002/jmv.29779
BibTeX
@article{Pathak2024,
author = {Pathak, Bharti and Chakarvarty, Aparna and Rani, Nakka Veena and Krishnan, Anuja},
title = {Serological immune biomarker for disease severity in dengue‐infected pediatric hospitalized patients},
journal = {Journal of Medical Virology},
year = {2024},
doi = {10.1002/jmv.29779}
}
EUVIMED